AVHEC 2019
AVHEC 2019

Poster Listing

Click on the presentation name to view the PDF poster

Poster numberPresenterPresentationAbstract
1Sandy DavidsonADDRESSING STIGMA ASSOCIATED WITH HEPATITIS B AMONG CHINESE AND KOREAN AUSTRALIANS: FAMILY HEALTH AND CANCER PREVENTIONAbstract
2Sandy DavidsonLET'S STICK TOGETHER TO CLOSE THE GAPAbstract
3Sha LiuIS SPEAKING THE SAME LANGUAGE GOOD ENOUGH? LESSONS LEARNT FROM WORKING WITH THE CHINESE COMMUNITY
Abstract
4Sambath MyMULTIPLE APROACHES TO AWARENESS ON VIRAL HEPATITIS B AND THE AVAILABILITY OF FREE VACCINE AMOUNG THE CAMBODIAN COMMUNITY IN SOUTH EAST MELBOURNEAbstract
5Sonam PaljorCHALLENGING CULTURAL ASSUMPTIONS BEYOND VIRAL HEPATITIS ELIMINATION: THE DIVERSITY HUB EXPERIENCEAbstract
6Evelyn PeSUPPORTING PEOPLE LIVING WITH CHRONIC HEPATITISB (CHB) IN THE MYANNMER COMMUNITYAbstract
7Aurora TangFROM PARTNERSHIP TO LEADERSHIP: VICTORIAN CHINESE COMMUNITY MOBILISE TO ELIMINATE HEPATITIS BAbstract
8Nicole AllardEVALUATING THE COVERAGE OF HEPATITIS B WORKFORCE DEVELOPMENT IN PRIMARY CAREAbstract
9Tanya ApplegateEVALUATION OF HCV RNA TESTING FROM FINGER-STICK CAPILLARY DRIED BLOOD SPOT AND VENEPUNTURE-COLLECTED SAMPLES: A COHORT STUDYAbstract
10David BakerNEVER FEAR- POLAR IS HERE; A NATIONALLY AVAILABLE TOOL FOR CHRONIC HEPATITIS B MANAGEMENT IN GENERAL PRACTICEAbstract
11Sofia BartlettHEPATITIS C VIRUS TREATMENT UPTAKE DIFFERS ACCORDING TO RECENCY OF OPIOID AGONIST THERAPY AMONG PEOPLE WHO INJECT DRUGS WITH CHRONIC HEPATITIS C INFECTIONAbstract
12Marian BloomfieldDRIED BLOOD SPOT FOR HIV AND HCV – TESTING PRIORITY POPULATION GROUPS IN THE NSW CUSTODIAL SETTINGAbstract
13Samantha BoltonHEPATITIS C TREATMENT IN PRISON: A FORUM FOR QUEENSLANDAbstract
14Rebecca Bowman****WITHDRAWN****RESISTANCE, REINFECTION OR RELAPSE: A CASE STUDY
15Lauren BradleyCUSTODIAL SETTINGS: THE MISSING LINK TO HEPATITIS C ELMINATIONAbstract
16Susan CampfieldCOMMUNITY-BASED MODEL OF CARE FOR HEPATITIS C TREATMENTAbstract
17Marilou CapatiEPIDEMIOLOGY OF CHRONIC HEPATITIS B IN A BULK-BILLING GP CLINIC IN DARWINAbstract
18Heidi Coupland"I'LL HAVE HEP C TREATMENT EVENTUALLY": SHEDDING LIGHT ON WHAT IT TAKES TO INCREASE HEPATITIS C TREATMENT UPTAKE WHEN CLIENTS HAVE OTHER PRIORITIESAbstract
19Evan CunninghamREINFECTION FOLLOWING SUCCESSFUL HCV DAA THERAPY AMONG PEOPLE WITH RECENT INJECTING DRUG USE OR CURRENT OPIOID SUBSTITUTION THERAPYAbstract
20Olivia DawsonHEPATITIS C EDUCATION FOR NSP FRONTLINE WORKERS: PRELIMINARY EVALUATION FINDINGS FROM A NATIONAL CAPACITY STRENGTHENING PROGRAMAbstract
21Julie-Anne DownieHEP C PROJECT INREACH 'SAME SAME BUT DIFFERENT SETTING’Abstract
22N/AN/A
23Marley EasterbrookOPEN-ACCESS HBV RESEARCH PROTOCOL DATABASEAbstract
24Annette FraserTHE ONE PHONE CALL AT A TIME APPROACH TO ELIMINATING HEPATITIS C IN THE WESTERN AUSTRALIAN COMMUNITYAbstract
25Louise GeddesSEX DISCREPANCIES IN THE PROTECTIVE EFFECT OF OPIOID AGONIST THERAPY ON INCIDENT HEPATITIS C INFECTIONAbstract
26Jason GrebelyHCV REINFECTION AND INJECTING RISK BEHAVIOR FOLLOWING ELBASVIR/GRAZOPREVIR TREATMENT IN PATIENTS ON OPIOD AGONIST THERAPY: CO-STAR PART BAbstract
27Brendan HarneyA NURSE-LED, COMMUNITY BASED MODEL OF HEPATITIS C CARE IN MELBOURNE, AUSTRALIA; 2017-2018Abstract
28Brendan HarneyHEPATITIS B IMMUNITY AND SUSCEPTABILITY AMONG PEOPLE LIVING WITH HIV AND HEPATITIS C CO-INFECTION IN MELBOURNE, AUSTRALIAAbstract
29Sichan HeEFFECTIVENESS OF DIRECT-ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C AMONG PEOPLE WITH HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSISAbstract
30Jo HoldenDRIED BLOOD SPOT (DBS) TESTING PILOTAbstract
31Dianne How ChowHEPATITIS C SPECIALIST NURSES USE NOTIFICATION DATA TO ENHANCE ENGAGEMENT WITH AND EDUCATION OF GENERAL PRACTITIONERS IN SOUTH EASTERN SYDNEY Abstract
32Dianne How ChowICHAT. EVALUATION OF AN INNOVATIVE NURSE LED PRIMARY HEALTH MODEL OF CARE FOR PATIENTS WITH HEPATITIS C IN INNER CITY SYDNEYAbstract
33Behzad HajariUPTAKE OF HEPATITIS C DIRECT-ACTING ANTIVIRAL TREATMENT AMONG INDIVIDUALS WITH HIV CO-INFECTION IN AUSTRALIAAbstract
34Hayden JoseIMPROVED HEPATITIS B TESTING AND MANAGEMENT AMONG GPS THAT HAVE COMPLETED S100 HEPATITIS B COMMUNITY PRESCRIBER PROGRAM TRAININGAbstract
35Shelley KerrREMOVING BARRIERS: AN ONLINE LEARNING MODULE FOR NURSES TO ELIMINATE STIGMA AND DISCRIMINATION TOWARDS PEOPLE LIVING WITH BLOOD-BORNE VIRUSESAbstract
36Chloe LaytonSUPPORTING PRIMARY CARE CLINICS TO PRIORITISE HEPATITIS C TESTING AND TREATMENT – THE EC NURSE-LED MODELAbstract
37Kyle LeadbeatterTHE VALUE OF A PEER AND CLINICAL PARTNERSHIP TO FACILITATE HEPATITIS C HEALTHCARE ACCESS IN PRIORITY SETTINGSAbstract
38Caroline LeeADHERENCE AND VIROLOGICAL OUTCOMES OF HEPATITIS B ANTIVIRAL THERAPY AMONGST INDIGENOUS AND NON-INDIGENOUS PATIENTS IN THE REMOTE TOP END, NORTHERN TERRITORYAbstract
39Alison MarshallBARRIERS AND FACILITATORS TO ENGAGING IN HCV MANAGEMENT AND DAA THERAPY AMONG GENERAL PRACTITIONERS AND DRUG AND AND ALCOHOL SPECIALISTS - THE PRACTITIONER EXPERIENCEAbstract
40Colette McgrathHEPATITIS IN PRISONS ELIMINATION (HIPE) PROGRAM, PHASE ONE: OUTCOMES AND LESSONS LEARNEDAbstract
41Kerrie MckenzieOPPORTUNISTIC ENGAGEMENT THROUGH NSPs IN A COMMUNITY SETTINGAbstract
42Winnie NguyenENHANCING HCV TREATMENT IN THE TRANSITION SPACE: HEPATITIS C PROBATION AND PAROLE PILOT IN SOUTH EAST QUEENSLANDAbstract
43Mim O'FlynnTOWARDS A CURE ON THE INSIDEAbstract
44Joss O'loanHCV IN THE AUSTRALIAN PRIMARY CARE SETTING: REAL WORLD EFFECTIVENESS OF 12 WEEKS OF SOFOSBUVIR/VELPATASVIR FOR THE TREATMENT OF CHRONIC HEPATITIS CAbstract
45Julie PageINDOCTRINATION –UPSKILLING DOCTORS IN REAL WORLD SETTINGSAbstract
46Anup John PereiraA LEAP IN THE RIGHT DIRECTION- DEBUNKING MYTHS, SOLIDIFYING ENGAGEMENT AND TRANSFORMING HEALTH ATTITUDES WITHIN CANBERRA’S MULTICULTURAL SETTINGSAbstract
47Meg PerrierHEPATITIS B ADULT MIGRANT EDUCATION; MOVING TOWARDS A SUSTAINABLE SPACEAbstract
48Jeffrey PostOPPORTUNISTIC ASSESSMENT AND TREATMENT OF PEOPLE WITH HEPATITIS C VIRUS INFECTION ADMITTED TO HOSPITAL FOR OTHER REASONS: A PROSPECTIVE COHORT STUDYAbstract
49Jeffrey PostSAFETY, EFFECTIVENESS AND POTENTIAL CONTIBUTION TO HEPATITIS C VIRUS (HCV) ELIMINATION OF A PRISON-BASED NURSE-LED HCV TREATMENT PROGRAM IN NSW, AUSTRALIAAbstract
50Darren RussellSO YOUR PRISON IS HEP C FREE – NOW WHAT?Abstract
51Darren RussellON THE ROAD TO MAKING 'CAIRNS HEP C FREE BY 2020' - ARE WE THERE YET?Abstract
52N/AN/A
53Nick ScottA GLOBAL INVESTMENT CASE FOR HEPATITIS CAbstract
54Linda Selvey***WITHDRAWN*** PERSONAL, PROVIDER AND SYSTEM LEVEL BARRIERS AND ENABLERS FOR HCV DAA TREATMENT IN GENERAL PRACTICE SETTINGS
55Christine SelveyUSE OF ROUTINE HEPATITS NOTIFICATION DATA TO SUPPORT DAA TREATMENT UPTAKE IN NEW SOUTH WALESAbstract
56Sarah SmithHEPATITIS B POP-UP SCREENING AT UNSW - WAS IT ALL WORTH IT?Abstract
57Sarah SmithHEPATITIS B COMMUNITY OUTREACH TESTING - SUCCESS THROUGH COLLABORATIONAbstract
58Sarah SmithTURNING OUTWARD: USING COMMUNITY CONVERSATIONS WITH PEOPLE WHO INJECT DRUGS IN SOUTHERN SYDNEY TO UNDERSTAND THE FACTORS INFLUENCING THEIR HEALTH AND WELLBEINGAbstract
59Azriel TanSUB-OPTIMAL PATTERNS OF HCV TESTING IN HOSPITALISED PEOPLE WHO INJECT DRUGS: A MISSED OPPORTUNITY?Abstract
60Alex ThompsonGLOBAL REAL WORLD EVIDENCE OF SOFOSBUVIR/VELPATASVIR AS A SIMPLE, EFFECTIVE REGIMEN FOR THE TREATMENT OF CHRONIC HEPATITIS C PATIENTS: INTEGRATED ANALYSIS OF 12 CLINICAL PRACTICE COHORTSAbstract
61Danika Tremain***WITHDRAWN***DRIED BLOOD SPOT TESTING IN DRUG AND ALCOHOL CLINICAL SERVICES: A PILOT STUDY
62Heather ValerioUPTAKE OF TESTING, LINKAGE TO CARE, AND TREATMENT FOR HEPATITIS C INFECTION AMONG PEOPLE WHO INJECT DRUGS IN AUSTRALIA: THE ETHOS ENGAGE STUDYAbstract
63Samantha WhiteBE LIVER SMART PROJECTAbstract
64Yinzong XiaoSYSTEMATIC REVIEW OF METHODS FOR THE SURVEILLANCE OF HEPATITIS B VIRUS IN LOW PREVALENCE COUNTRIES, 2017Abstract
65Matthew YoungTHE KOMBI CLINIC – IT’S THE END OF THE ROAD FOR HEPATITIS CAbstract
66Sahar BajisHEPATITIS C VIRUS TESTING, LIVER DISEASE ASSESSMENT AND TREATMENT UPTAKE AMONG PEOPLE WHO INJECT DRUGS PRE- AND POST-UNIVERSAL ACCESS TO DIRECT-ACTING ANTIVIRAL TREATMENT IN AUSTRALIA: THE LIVERLIFEAbstract
67Anne BalcombAUSTRALIAN RURAL PRIMARY CARE LED VIRAL HEPATITIS CLINIC - OUTCOME DATA FROM 3 YEARS OF DIRECT ACTING ANTIVIRAL AGENTS (DAA'S)Abstract
68Bridget DraperCOMMUNITY-BASED POINT-OF-CARE TESTING AND TREATMENT FOR PEOPLE WHO INJECT DRUGS AND GENERAL POPULATION IN MYANMARAbstract
69Ingrid FrancisCOLLABORATIVE APPROACH TO THE MANAGEMENT OF HEPATITIS C AT NUMINBAH QUEENSLAND CORRECTIONAL FACILITYAbstract
70Peta GavaNOTHING ABOUT US WITHOUT US: THE ROLE OF PEER EDUCATORS IN HCV TESTING AND TREATMENT UPTAKEAbstract
71Jake WilliamsUNIVERSAL BLOOD-BORNE VIRUS SCREENING IN PATIENTS WITH SEVERE MENTAL ILLNESS MANAGED IN AN OUTPATIENT CLOZAPINE CLINIC: UPTAKE AND PREVALENCEYAbstract
72Alisa PedranaHEPATITIS C ANTIBODY TESTING TREND PRE AND POST UNIVERSAL ACCESS TO DIRECT ACTING ANTIVIRALS IN AUSTRALIA: SEGMENTED REGRESSION OF PRIMARY CARE CLINIC DATAAbstract
73Alisa PedranaA GLOBAL INVESTMENT FRAMEWORK FOR HEPATITIS C ELIMINATIONAbstract
74Alisa PedranaKNOWLEDGE OF HEPATITIS C TESTING AND TREATMENT GUIDELINES AMONG PEOPLE AT RISK OF, OR LIVING WITH, HEPATITIS C.Abstract
75Alisa PedranaTAILORING HEPATITIS C HEALTH PROMOTION FOR PEOPLE WHO INJECT DRUGS

Abstract
76Neil Arvin BretanaA COMBINED TREATMENT AND PREVENTION APPROACH IS VITAL IN ELIMINATING HEPATITIS C VIRUS IN AUSTRALIAN PRISONS: A MODELLING STUDYAbstract
77Jennifer MacLachlanEPIDEMIOLOGY OF CHRONIC HEPATITIS B AND C IN VICTORIA: INSIGHTS AND IMPACTS FROM ENHANCED SURVEILLANCEAbstract
78Anna PalmerA COST-EFFECTIVENESS ANALYSIS OF PRIMARY VERSUS HOSPITAL-BASED SPECIALIST CARE FOR DIRECT ACTING ANTIVIRAL HEPATITIS C TREATMENTAbstract
79Jasmine YeeHIGH EFFICACY OF DIRECT-ACTING ANTIVIRAL THERAPY FOR CHRONIC HCV IN AN AUSTRALIAN REAL-WORLD COHORT: THE REACH-C STUDYAbstract
80Rosie GilliverACCESSING HIDDEN POPULATIONS: AN EXTENDED OUTREACH SERVICE OF THE KIRKETON ROAD CENTREAbstract
81Phillip ReadPARTNERING WITH CONSUMERS: THE DEVELOPMENT OF A PRIMARY HEALTH CARE HEPATITIS C TREATMENT MODEL WITHIN A PEER-BASED NEEDLE AND SYRINGE PROGRAMAbstract
82Phillip ReadWHEN TREATMENT ACCESS DOES NOT EQUAL TREATMENT INITIATION: AN ANALYSIS OF CLIENTS WHO DO NOT INITIATE DIRECT ACTING ANTIVIRALSAbstract